Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Theander

Showing results (321-330 of 329) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 329 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2019
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated MalariaBenjamin Mordmüller, Mihály Sulyok, Diane Egger-Adam, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Broadly inhibitory antibodies against severe malaria virulence proteinsRaphael A Reyes, Sai Sundar Rajan Raghavan, Nicholas K Hurlburt, et al.
The Lancet. Microbe|January 21, 2023
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2Merel J Smit, Adam F Sander, Maud B P A Ariaans, et al.
Nature|November 20, 2024
Broadly inhibitory antibodies to severe malaria virulence proteinsRaphael A Reyes, Sai Sundar Rajan Raghavan, Nicholas K Hurlburt, et al.
Cancer Cell|October 14, 2015
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria ProteinAli Salanti, Thomas M Clausen, Mette Ø Agerbæk, et al.
Lab Animal|November 6, 2023
Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSAJustin Doritchamou, Morten A Nielsen, Arnaud Chêne, et al.
Nature Communications|August 30, 2024
Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfateElena Ethel Vidal-Calvo, Anne Martin-Salazar, Swati Choudhary, et al.
Nature Communications|January 13, 2021
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activityCyrielle Fougeroux, Louise Goksøyr, Manja Idorn, et al.
The New England Journal of Medicine|November 10, 2012
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants, Selidji Todagbe Agnandji, Bertrand Lell, et al.
Pageof 33

Showing results (321-330 of 329) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 329 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2019
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated MalariaBenjamin Mordmüller, Mihály Sulyok, Diane Egger-Adam, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Broadly inhibitory antibodies against severe malaria virulence proteinsRaphael A Reyes, Sai Sundar Rajan Raghavan, Nicholas K Hurlburt, et al.
The Lancet. Microbe|January 21, 2023
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2Merel J Smit, Adam F Sander, Maud B P A Ariaans, et al.
Nature|November 20, 2024
Broadly inhibitory antibodies to severe malaria virulence proteinsRaphael A Reyes, Sai Sundar Rajan Raghavan, Nicholas K Hurlburt, et al.
Cancer Cell|October 14, 2015
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria ProteinAli Salanti, Thomas M Clausen, Mette Ø Agerbæk, et al.
Lab Animal|November 6, 2023
Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSAJustin Doritchamou, Morten A Nielsen, Arnaud Chêne, et al.
Nature Communications|August 30, 2024
Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfateElena Ethel Vidal-Calvo, Anne Martin-Salazar, Swati Choudhary, et al.
Nature Communications|January 13, 2021
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activityCyrielle Fougeroux, Louise Goksøyr, Manja Idorn, et al.
The New England Journal of Medicine|November 10, 2012
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants, Selidji Todagbe Agnandji, Bertrand Lell, et al.
Pageof 33